Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hasle

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Leukemia|February 12, 1999
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)C Flotho, S Valcamonica, S Mach-Pascual, et al.
Leukemia|April 20, 2007
Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndromeJ H Klusmann, D Reinhardt, H Hasle, et al.
Danish Medical Bulletin|October 1, 1990
Psychotropic medication in the elderly. A survey of prescribing and clinical outcomeR B Olsen, S U Gydesen, M Kristensen, et al.
Blood|January 7, 1998
Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient miceP O Iversen, I D Lewis, S Turczynowicz, et al.
Leukemia|March 16, 2007
Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndromeA Karow, D Steinemann, G Göhring, et al.
Leukemia|November 24, 2005
Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trialsS O Lie, J Abrahamsson, N Clausen, et al.
Leukemia|December 7, 2007
Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AMLH Hasle, J Abrahamsson, M Arola, et al.
Contemporary Clinical Trials|December 24, 2023
Engaging carers in neuropsychological rehabilitation for brain cancer survivors: The "I'm aware: Patients And Carers Together" (ImPACT) programC R Buskbjerg, A Amidi, A Munk, et al.
Leukemia|December 8, 2006
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemiaM Zecca, G Bergamaschi, C Kratz, et al.
Leukemia|October 22, 2004
The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)H Hasle, I Baumann, E Bergsträsser, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Leukemia|February 12, 1999
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)C Flotho, S Valcamonica, S Mach-Pascual, et al.
Leukemia|April 20, 2007
Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndromeJ H Klusmann, D Reinhardt, H Hasle, et al.
Danish Medical Bulletin|October 1, 1990
Psychotropic medication in the elderly. A survey of prescribing and clinical outcomeR B Olsen, S U Gydesen, M Kristensen, et al.
Blood|January 7, 1998
Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient miceP O Iversen, I D Lewis, S Turczynowicz, et al.
Leukemia|March 16, 2007
Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndromeA Karow, D Steinemann, G Göhring, et al.
Leukemia|November 24, 2005
Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trialsS O Lie, J Abrahamsson, N Clausen, et al.
Leukemia|December 7, 2007
Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AMLH Hasle, J Abrahamsson, M Arola, et al.
Contemporary Clinical Trials|December 24, 2023
Engaging carers in neuropsychological rehabilitation for brain cancer survivors: The "I'm aware: Patients And Carers Together" (ImPACT) programC R Buskbjerg, A Amidi, A Munk, et al.
Leukemia|December 8, 2006
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemiaM Zecca, G Bergamaschi, C Kratz, et al.
Leukemia|October 22, 2004
The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)H Hasle, I Baumann, E Bergsträsser, et al.
Pageof 9